DE60133627D1 - Das hohe expression in prostatakrebs aufweist - Google Patents

Das hohe expression in prostatakrebs aufweist

Info

Publication number
DE60133627D1
DE60133627D1 DE60133627T DE60133627T DE60133627D1 DE 60133627 D1 DE60133627 D1 DE 60133627D1 DE 60133627 T DE60133627 T DE 60133627T DE 60133627 T DE60133627 T DE 60133627T DE 60133627 D1 DE60133627 D1 DE 60133627D1
Authority
DE
Germany
Prior art keywords
fragment
cancers
prostate cancer
encoded protein
high expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60133627T
Other languages
English (en)
Other versions
DE60133627T2 (de
Inventor
Aya Jakobovits
Daniel E Afar
Pia M Challita-Eid
Elana Levin
Steve Chappell Mitchell
Rene S Hubert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agensys Inc
Original Assignee
Agensys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agensys Inc filed Critical Agensys Inc
Publication of DE60133627D1 publication Critical patent/DE60133627D1/de
Application granted granted Critical
Publication of DE60133627T2 publication Critical patent/DE60133627T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DE60133627T 2000-01-26 2001-01-26 84p2a9: prostata- und testis-spezifisches protein das hohe expression in prostatakrebs aufweist Expired - Lifetime DE60133627T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17856000P 2000-01-26 2000-01-26
US178560P 2000-01-26
PCT/US2001/002651 WO2001055391A2 (en) 2000-01-26 2001-01-26 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer

Publications (2)

Publication Number Publication Date
DE60133627D1 true DE60133627D1 (de) 2008-05-29
DE60133627T2 DE60133627T2 (de) 2009-07-30

Family

ID=22653018

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60133627T Expired - Lifetime DE60133627T2 (de) 2000-01-26 2001-01-26 84p2a9: prostata- und testis-spezifisches protein das hohe expression in prostatakrebs aufweist
DE60144204T Expired - Lifetime DE60144204D1 (de) 2000-01-26 2001-01-26 84P2A9: Prostata- und hodenspezifisches Protein, das sehr stark bei Prostatakrebs vorkommt

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60144204T Expired - Lifetime DE60144204D1 (de) 2000-01-26 2001-01-26 84P2A9: Prostata- und hodenspezifisches Protein, das sehr stark bei Prostatakrebs vorkommt

Country Status (12)

Country Link
US (3) US7510855B2 (de)
EP (2) EP1967586B1 (de)
JP (2) JP3946044B2 (de)
AT (2) ATE392474T1 (de)
AU (2) AU3797301A (de)
CA (1) CA2398064C (de)
CY (1) CY1111522T1 (de)
DE (2) DE60133627T2 (de)
DK (1) DK1967586T3 (de)
ES (2) ES2360155T3 (de)
IL (2) IL150873A0 (de)
WO (1) WO2001055391A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2360155T3 (es) * 2000-01-26 2011-06-01 Agensys, Inc. 84p2a9: una proteína específica de próstata y testículos altamente expresada en el cáncer de próstata.
US8168181B2 (en) * 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
CA2638823A1 (en) * 2006-02-13 2007-08-23 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in the process of bone remodeling
US9493562B2 (en) 2012-07-19 2016-11-15 Alethia Biotherapeutics Inc. Anti-Siglec-15 antibodies
SG10201701828WA (en) * 2012-09-07 2017-04-27 Agency Science Tech & Res Peptides and their uses

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8724885D0 (en) 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
TR199902053T2 (xx) 1997-02-25 2000-04-21 Corixa Corporation Prostat kanserinin immunoterapisine y�nelik bile�ikler ve bunlar�n kullan�lmas�na matuf metodlar.
JP2001519666A (ja) 1997-04-10 2001-10-23 ジェネティックス・インスチチュート・インコーポレーテッド 分泌発現配列タグ（ｓＥＳＴｓ）
WO1999038972A2 (en) 1998-01-28 1999-08-05 Chiron Corporation Human genes and gene expression products ii
US6013450A (en) 1998-02-20 2000-01-11 Incyte Pharmaceuticals, Inc. CAF1-related protein
CA2296792A1 (en) 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
EP1074617A3 (de) 1999-07-29 2004-04-21 Research Association for Biotechnology Primers für Synthese von ganzen-Länge cDNS und deren Anwendung
AU2001229340A1 (en) 2000-01-14 2001-07-24 Millennium Pharmaceuticals, Inc. Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
ES2360155T3 (es) * 2000-01-26 2011-06-01 Agensys, Inc. 84p2a9: una proteína específica de próstata y testículos altamente expresada en el cáncer de próstata.
WO2001059064A2 (en) 2000-01-31 2001-08-16 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
US6436703B1 (en) 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
AU2001249642A1 (en) 2000-04-06 2001-10-23 Genetics Institute, Llc Polynucleotides encoding novel secreted proteins
CN1328147A (zh) 2000-06-12 2001-12-26 上海博德基因开发有限公司 一种新的多肽——人磷脂酶49.06和编码这种多肽的多核苷酸
US6974667B2 (en) 2000-06-14 2005-12-13 Gene Logic, Inc. Gene expression profiles in liver cancer
EP1305450A2 (de) 2000-07-28 2003-05-02 Compugen Inc. Oligonukleotidbibliothek für die detektion der rna-transkripten und splicevarianten eines transkriptoms
EP1346040A2 (de) 2000-09-11 2003-09-24 Nuvelo, Inc. Nukleinsäuren und polypeptide
WO2002031111A2 (en) 2000-10-12 2002-04-18 Hyseq, Inc. Novel nucleic acids and polypeptides
US20070015148A1 (en) 2001-01-25 2007-01-18 Orr Michael S Gene expression profiles in breast tissue

Also Published As

Publication number Publication date
JP2006325595A (ja) 2006-12-07
US7582448B2 (en) 2009-09-01
JP3946044B2 (ja) 2007-07-18
IL150873A0 (en) 2003-02-12
US20090170191A1 (en) 2009-07-02
CA2398064A1 (en) 2001-08-02
AU2001237973B2 (en) 2006-09-07
EP1250434A2 (de) 2002-10-23
WO2001055391A2 (en) 2001-08-02
WO2001055391A3 (en) 2002-02-21
EP1250434B1 (de) 2008-04-16
ES2304126T3 (es) 2008-09-16
DE60133627T2 (de) 2009-07-30
CY1111522T1 (el) 2015-08-05
DK1967586T3 (da) 2011-06-20
ATE392474T1 (de) 2008-05-15
CA2398064C (en) 2012-12-18
ATE501255T1 (de) 2011-03-15
ES2360155T3 (es) 2011-06-01
US7510855B2 (en) 2009-03-31
EP1967586B1 (de) 2011-03-09
IL150873A (en) 2010-02-17
US8013126B2 (en) 2011-09-06
DE60144204D1 (de) 2011-04-21
JP2003520605A (ja) 2003-07-08
EP1967586A1 (de) 2008-09-10
JP5501550B2 (ja) 2014-05-21
AU3797301A (en) 2001-08-07
US20040126862A1 (en) 2004-07-01
US20070054363A1 (en) 2007-03-08

Similar Documents

Publication Publication Date Title
WO2005062972A3 (en) Treatment of cancer with novel anti-il 13 monoclonal antibodies
ATE420175T1 (de) C-typ lektin transmembranantigen, das in menschlichen prostatkrebs exprimiert wird, und deren verwendungen
PT1349870E (pt) Composições para a terapêutica e diagnóstico do cancro do ovário
TR200001646T2 (tr) Bir salgılanmış meme kanseri proteini olan mamaglobin.
BR9908823A (pt) Compostos e processos para terapia e diagnóstico de câncer de pulmão
WO1998045328A3 (en) Compositions and methods for the treatment and diagnosis of breast cancer
DE60126495D1 (de) Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten
BR0010702A (pt) Novas quinonas como terapias de doenças
CY1111522T1 (el) 84p2a9: ειδικη σε προστατη και ορχεις πρωτεϊνη που εκφραζεται σε υψηλο βαθμο στον προστατικο καρκινο
AU2001235761A1 (en) Diagnosis of breast cancer using bcmp-11 as marker
DE60326931D1 (de) In kanzerösen mammazellen differentiell exprimierte genprodukte und ihre verwendungsverfahren
DE60130541D1 (de) Gewebe-spezifische protein 103p2d6, hochexprimiert in verschiedene krebsarten
DK1313850T3 (da) Nucleinsyre og tilsvarende protein med navnet 85PB3 anvendelige til behandling og påvisning af cancer
WO2001059110A3 (en) 34p3d7: a tissue specific protein highly expressed in prostate cancer
WO2001059115A3 (en) 83p5g4: a tissue specific protein highly expressed in prostate cancer
WO2003020954A3 (en) 205p1b5 in treatment and detection of cancer
WO2001078755A3 (fr) Nouveau polypeptide, proteine humaine de mutation 9 de l'ataxie-telangiectasie, et polynucleotide codant pour ce polypeptide
WO2001081536A3 (fr) Nouveau polypeptide, proteine kinase ysk1 humaine 10, et polynucleotide codant pour ce polypeptide
WO2001075001A3 (fr) Nouveau polypeptide, protéine kinase humaine dépendant de l'adénosine cyclique 9, et poynucléotide codant pour ce polypeptide
WO2001075035A3 (fr) Nouveau polypeptide, peroxydase proteine humaine 9, et polynucleotide codant pour ce polypeptide
WO2001075034A3 (fr) Nouveau polypeptide, peroxydase proteine humaine 15, et polynucleotide codant pour ce polypeptide
ES1032302U (es) Plantilla higienica monouso desechable.
WO2001075024A3 (fr) Nouveau polypeptide, facteur humain 13 associe a nf-e2, et polynucleotide codant pour ce polypeptide
WO2001075053A3 (fr) Nouveau polypeptide, chaperonine humaine 14, et polynucleotide codant pour ce polypeptide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition